The impact of asthma on the gastrointestinal tract (GIT)

Journal of Asthma and Allergy

Volumn 3, Issue , 2010, Pages 123-130

  Vieira, Warren Antonio ^a   Pretorius, Etheresia ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Asthma; Common mucosal system; Fundus; Gastrointestinal tract; Pylorus

Indexed keywords

EID: 85002855606     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S10592     Document Type: Review

References (48)

1. Gartner LP, Hiatt JL. Color atlas of histology. 2nd ed. Baltimore: Williams & Wilkins; 1994.
2. Wheater PR, Burkitt HG, Daniels VG. Functional histology. 2nd ed. Edinburgh: Churchill Livingstone; 1987.
3. Rudzik R, Clancy RL, Perey DYE, Day RP, Bienenstock J. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer’s patch and bronchial lymphocytes. J Immunol. 1975;114:1599-1604.
4. Nauta AJ, Engels F, Knippels LM, Garssen J, Nijkamp FP, Redegeld FA. Mechanism of allergy and asthma. Eur J Pharmacol. 2008;585:354-360.
5. Wallaert B, Desreumaux P, Copin MC, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med. 1995;182(6):1897-1904.
6. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel AB, Wallaert B. Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol. 1996;97(6):1173-1178.
7. Nepomnyashchikh GI, Chernyavskaya GM, Aidagulova SV. Korabel’nikov DI. Ultrastructural changes in cells of the gastric and small intestinal mucosa during bronchial asthma. Bull Exp Biol Med. 2004;137(3):341-346.
8. Coetzee HL, Loots GP, Meiring JH. Human histology. Pretoria: van Schaik Publishers; 2003.
9. Eroschenko VP. diFiore’s atlas of histology with functional correlations. 10th ed. New York: Lippincott Williams & Wilkins; 2005.
10. Rohrer V. Human gastric mucosa: correlation of structure and function. Am J Clin Nutr. 1971;24:137-143.
11. Wilson JW, Kotsmbos T. Airway vascular remodeling in asthma. Curr Allergy Asthma Rep. 2003;3:153-158.
12. Mauad T, Bel EH, Sterk PJ. Asthma therapy and airway remodeling. J Allergy Clin Immunol. 2007;120(5):997-1009.
13. Sumi Y. Hamis Q. Airway remodeling in asthma. Allergol Int. 2007;56(4):341-348.
14. Warner SM, Knight DA. Airway modeling and remodeling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2008;8(1):44-48.
15. Walters EH, Soltani A, Reid DW, Ward C. Vascular remodeling in asthma. Curr Opin Allergy Clin Immunology. 2008;8(1):39-43.
16. Awang-Hazmi AJ, Zuki ABZ, Zamri-Saas M, Po Po S. The response of gut associated lymphoid tissues (GALT) flowing oral administration of P.Multocida B2 in rats. Vet On-Line [serial on the Internet]. 2007 [cited 2009 Oct 6]. http://www.priory.com/vet/peyers.htm. Accessed Oct 6, 2009.
17. Wang WH. Observations on aggregated lymphoid nodules in the cardiac glandular areas of the Bacterian camel (Camelus bacterianus). Vet J. 2003;166(2):205-209.
18. Coombes JL, Maloy KJ. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol. 2007;19:116-126.
19. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38:709-750.
20. Kay AB. Leukocytes in asthma. Immunol Invest. 1988;17:679-705.
21. Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmaco. 2003;3(4):443-448.
22. D’Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview. J Immunol Methods. 2003;273: 3-13.
23. Gwinn WM, Damsker JM, Falahati R, et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol. 2006;177:4870-4879.
24. Kelly M, Hwang JM., Kubes P. Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol. 2007;120:3-10.
25. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. Edinburgh: Churchill Livingstone; 2003.
26. Rogers DF. Airway goblet cell hyperplasia in asthma: Hypersecretory and anti-inflammatory? Clin Exp Allergy. 2002;32: 1124-1127.
27. Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest. 2002;122:320S-326S.
28. Gordon BR. Asthma history and presentation. Otolaryngol Clin North Am. 2008;41(2):375-385.
29. Nelson DL, Cox MM. Lehninger, principles of biochemistry. 4th ed. New York: W. H. Freeman and Company; 2005.
30. Kips JC. Cytokines in asthma. Eur Respir J. 2001;18:S24-S33.
31. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Boil Med. 2003;35(3): 213-225.
32. Lupher ML, Gallatin WM. Regulation of fibrosis by the immune system. Adv Immunol. 2006;89:245-288.
33. Smit JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol. 2006;533:277-288.
34. Doganci A, Neurath MF, Finotto S. Mucosal immunoregulation: transcription factors as possible therapeutic targets. Curr Drug Targets. 2005;4:565-575.
35. Platt AM, Mowat AM. Mucosal macrophages and the regulation of immune responses in the intestine. Immunol Letters. 2008;119: 22-31.
36. Schenk M, Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Semin Immunol. 2007;19:84-93.
37. Bengmark S. Synbiotics and the mucosal barrier in critically ill patients. Curr Opin Gastroenterol. 2005;21:712-716.
38. Langman JM, Rowland R. The number and distribution of lymphoid follicles in the human large intestine. J Anat. 1986;194:189-194.
39. Ozdemir C, Sel S, Schöll I, et al. CD4+ T cells from mice with intestinal immediate-type hypersensitivity induced airway hyperreactivity. Clin Exp Allergy. 2007;37(10):1419-1426.
40. Rogers DF. Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J. 1994;7:1690-1706.
41. The Center for Cancer Education-Villous atrophy [homepage on the Internet]. Newcastle: University of Newcastle; [updated 2000 Mar 05; cited 2009 Jan 31]. Available from: http://cancerweb.ncl.ac.uk/cgi-bin/omd?villous+atrophy
42. Ullrich R, Zeitz M, Heise W, et al. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med. 1989;111:15-21.
43. Beaugerie L, Carbonnel F, Carrat F, et al. Factors of weight loss in patients with HIV and chronic diarrhea. AIDS Hum Retroviruses. 1998;19:34-39.
44. Kotler DP. HIV infection and the gastrointestinal tract. AIDS. 2005;19:107-117.
45. Sestak K. Chronic diarrhea and AIDS: insight into studies with nonhuman primates. Curr HIV Res. 2005;3:199-205.
46. Sankaran S, Guadalupe M, Reay E, et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. PNAS. 2005;102: 9860-9865.
47. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-Cell Depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77:11708-11717.
48. Kotler DP. Intestinal disease associated with HIV infection: Characterization and response to antiretroviral therapy. Pathobiology. 1998;66:183-189.